Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Metaraminol bitartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaraminol bitartrate and what is the scope of metaraminol bitartrate patent protection?

Metaraminol bitartrate
is the generic ingredient in two branded drugs marketed by Merck, Gd Searle Llc, Fresenius Kabi Usa, Abraxis Pharm, and Elkins Sinn, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: metaraminol bitartrate

Bulk Api Vendors: see list31
Clinical Trials: see list20
Patent Applications: see list491
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:metaraminol bitartrate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc
metaraminol bitartrate
INJECTABLE;INJECTION086418-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Gd Searle Llc
metaraminol bitartrate
INJECTABLE;INJECTION086418-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Abraxis Pharm
metaraminol bitartrate
INJECTABLE;INJECTION080431-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
metaraminol bitartrate
INJECTABLE;INJECTION009509-002Dec 22, 1987DISCNYesNo► Subscribe► Subscribe
Fresenius Kabi Usa
metaraminol bitartrate
INJECTABLE;INJECTION080722-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus